patient-centric trials therapeutic development precision oncology 
enhanced understanding molecular pathology disease gained genomic studies facilitating development treatments target discrete molecular subclasses tumours considerable associated challenges include advance implement targeted drug-development strategies precision medicine centres delivering appropriate therapy patient basis clinical molecular features disease development therapeutic agents target molecular mechanisms driving innovation clinical-trial strategies although progress made modifications existing core paradigms oncology drug development will required realize fully promise precision medicine 
